Literature DB >> 2265389

Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation.

D L Dunn1.   

Abstract

Renal transplantation is associated with many long-term complications caused by a combination of the patient's comorbid medical illnesses and the effects of the various maintenance immunosuppressive agents currently in use. Careful patient selection with an emphasis on adequate cardiovascular function and low maintenance doses of immunosuppression at a level compatible with graft acceptance should help to prevent significant long-term morbidity. Recurrence of the original renal disease is a common histologic finding but, except in a few diseases, rarely results in graft loss. Parenthood can be a reality for most patients who have excellent graft function.

Entities:  

Mesh:

Year:  1990        PMID: 2265389

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  8 in total

1.  Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.

Authors:  G V Mazariegos; H Ramos; R Shapiro; A Zeevi; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

2.  Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection.

Authors:  T Spencer Skelton; Neelam Tejpal; Yongquan Gong; Malgorzata Kloc; Rafik M Ghobrial
Journal:  Transpl Immunol       Date:  2010-07-06       Impact factor: 1.708

3.  Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.

Authors:  Mepur H Ravindranath; Edward J Filippone; Grace Mahowald; Carly Callender; Adarsh Babu; Susan Saidman; Soldano Ferrone
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

Review 4.  Science of composite tissue allotransplantation.

Authors:  Bruce Swearingen; Kadiyala Ravindra; Hong Xu; Shengli Wu; Warren C Breidenbach; Suzanne T Ildstad
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

5.  Transplant chimerism in porcine structural vascularized bone allotransplants.

Authors:  Rudolph H Houben; Ross A Aleff; Patricia F Friedrich; Alexander Y Shin; Eric D Wieben; Andre J van Wijnen; Allen T Bishop
Journal:  Gene       Date:  2020-03-26       Impact factor: 3.688

6.  Specific immunosuppression by mixed chimerism with bone marrow transplantation after Staphylococcal Enterotoxin B pretreatment could prolong corneal allograft survival in mice.

Authors:  Yingnan Zhang; Zhiqiang Pan; Yu Chen; Ying Jie; Yan He
Journal:  Mol Vis       Date:  2012-04-18       Impact factor: 2.367

7.  Down regulation of genes involved in T cell polarity and motility during the induction of heart allograft tolerance by allochimeric MHC I.

Authors:  Wojciech Lisik; Neelam Tejpal; Yongquan Gong; T Spencer Skelton; Malathesh Ganachari; Eric G Bremer; Malgorzata Kloc; Rafik M Ghobrial
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

Review 8.  Post-cardiac transplant recipient: Implications for anaesthesia.

Authors:  Minati Choudhury
Journal:  Indian J Anaesth       Date:  2017-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.